» Articles » PMID: 22261065

The Loop 5 Element Structurally and Kinetically Coordinates Dimers of the Human Kinesin-5, Eg5

Overview
Journal Biophys J
Publisher Cell Press
Specialty Biophysics
Date 2012 Jan 21
PMID 22261065
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Eg5 is a homotetrameric kinesin-5 motor protein that generates outward force on the overlapping, antiparallel microtubules (MTs) of the mitotic spindle. Upon binding an MT, an Eg5 dimer releases one ADP molecule, undergoes a slow (∼0.5 s(-1)) isomerization, and finally releases a second ADP, adopting a tightly MT-bound, nucleotide-free (APO) conformation. This conformation precedes ATP binding and stepping. Here, we use mutagenesis, steady-state and pre-steady-state kinetics, motility assays, and electron paramagnetic resonance spectroscopy to examine Eg5 monomers and dimers as they bind MTs and initiate stepping. We demonstrate that a critical element of Eg5, loop 5 (L5), accelerates ADP release during the initial MT-binding event. Furthermore, our electron paramagnetic resonance data show that L5 mediates the slow isomerization by preventing Eg5 dimer heads from binding the MT until they release ADP. Finally, we find that Eg5 having a seven-residue deletion within L5 can still hydrolyze ATP and move along MTs, suggesting that L5 is not required to accelerate subsequent steps of the motor along the MT. Taken together, these properties of L5 explain the kinetic effects of L5-directed inhibition on Eg5 activity and may direct further interventions targeting Eg5 activity.

Citing Articles

Mitotic Functions and Characters of KIF11 in Cancers.

Gao W, Lu J, Yang Z, Li E, Cao Y, Xie L Biomolecules. 2024; 14(4).

PMID: 38672404 PMC: 11047945. DOI: 10.3390/biom14040386.


Noncanonical interaction with microtubules via the N-terminal nonmotor domain is critical for the functions of a bidirectional kinesin.

Singh S, Siegler N, Pandey H, Yanir N, Popov M, Goldstein-Levitin A Sci Adv. 2024; 10(6):eadi1367.

PMID: 38324691 PMC: 10849588. DOI: 10.1126/sciadv.adi1367.


Using a comprehensive approach to investigate the interaction between Kinesin-5/Eg5 and the microtubule.

Guo W, Sun S, Sanchez J, Lopez-Hernandez A, Ale T, Chen J Comput Struct Biotechnol J. 2022; 20:4305-4314.

PMID: 36051882 PMC: 9396395. DOI: 10.1016/j.csbj.2022.08.020.


MD simulation-based screening approach identified tolvaptan as a potential inhibitor of Eg5.

Sebastian J, Raghav D, Rathinasamy K Mol Divers. 2022; 27(3):1203-1221.

PMID: 35789974 DOI: 10.1007/s11030-022-10482-w.


Cryo-EM structure of a microtubule-bound parasite kinesin motor and implications for its mechanism and inhibition.

Cook A, Roberts A, Atherton J, Tewari R, Topf M, Moores C J Biol Chem. 2021; 297(5):101063.

PMID: 34375637 PMC: 8526983. DOI: 10.1016/j.jbc.2021.101063.


References
1.
Krzysiak T, Gilbert S . Dimeric Eg5 maintains processivity through alternating-site catalysis with rate-limiting ATP hydrolysis. J Biol Chem. 2006; 281(51):39444-54. PMC: 1866285. DOI: 10.1074/jbc.M608056200. View

2.
Liu L, Parameswaran S, Liu J, Kim S, Wojcik E . Loop 5-directed compounds inhibit chimeric kinesin-5 motors: implications for conserved allosteric mechanisms. J Biol Chem. 2010; 286(8):6201-10. PMC: 3057856. DOI: 10.1074/jbc.M110.154989. View

3.
Brier S, Lemaire D, DeBonis S, Forest E, Kozielski F . Molecular dissection of the inhibitor binding pocket of mitotic kinesin Eg5 reveals mutants that confer resistance to antimitotic agents. J Mol Biol. 2006; 360(2):360-76. DOI: 10.1016/j.jmb.2006.04.062. View

4.
Cochran J, Krzysiak T, Gilbert S . Pathway of ATP hydrolysis by monomeric kinesin Eg5. Biochemistry. 2006; 45(40):12334-44. PMC: 2288585. DOI: 10.1021/bi0608562. View

5.
Kantarjian H, Padmanabhan S, Stock W, Tallman M, Curt G, Li J . Phase I/II multicenter study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of AZD4877 in patients with refractory acute myeloid leukemia. Invest New Drugs. 2011; 30(3):1107-15. PMC: 4205950. DOI: 10.1007/s10637-011-9660-2. View